LAVVAN is focused on the production of high-quality and reliably sourced cannabinoids for a range of end markets.

In collaboration with Amyris, LAVVAN is developing fermentation based technology to unlock the full potential of the cannabinoid family of molecules.

LAVVAN is backed by leaders across the cannabis, food and beverage, and pharmaceutical industries.


Neil Closner

Etan Bendheim

Dr. Jeremy N. Friedberg
Chief Science Officer

Angelo Fefekos
SVP, Regulatory Affairs & Quality Assurance

Adam Noyek
SVP, Operations

Umar Syed
Senior Advisor, Product Strategy

Alexia Blake
Director, Product Development

Istok Nahtigal
Director, Process Sciences

Ori Sher
Director, Infrastructure


Strategic Advisory Board

Michael Bush
Managing Partner at GrowthWay Partners

Carol Hamilton
Group President, Luxe Division, L'Oréal

Jesse Itzler
Founder at The 100 Mile Group

Brian Loeb
Investor at CGC Ventures

David Sable
Non-Executive Chairman at VMLY&R

Stephen Sadove
Former CEO of Saks Inc.


Name *